Topic: Miscellaneous

Nasdaq Amends 20% Private Placement Shareholder Approval Rule
EDNY Rejects Motion to Dismiss in First ICO Criminal Securities Fraud Trial
SEC Streamlines Disclosure Requirements as Part of its Overall Disclosure Effectiveness Review
The SEC Continues to Modernize and Adapt to the Times
The SEC's Proposed Transaction Fee Pilot for US Equity Securities
SEC Significantly Expands Confidential Review of Registration Statements
SEC Eliminates Need for Affirmative “Tandy” Representations from Issuers
NASDAQ Proposes Disclosure of Third-Party Compensation for Directors and Nominees
When the Tail Wags the Unicorn: SEC Chair Voices Concerns About Pre-IPO Investments
SEC Files Fraud Charges Against Public Biotechnology Company and its Officers for Alleged Materially Misleading FDA-Related Disclosures
1 - 10 Next

 Error

Web Part Error: A Web Part or Web Form Control on this Page cannot be displayed or imported. The type could not be found or it is not registered as safe. Correlation ID: 5ad4a19e-0928-c0be-c3d3-9c239ed5746d.

© Copyright 2018 Gibson, Dunn & Crutcher LLP.
Attorney Advertising. Prior results do not guarantee a similar outcome. All information provided on this site is for informational purposes only, does not constitute legal advice, is not confidential, and does not create an attorney-client relationship. Statements and content posted to this site do not represent the opinion of Gibson Dunn & Crutcher LLP ("Gibson Dunn"). Gibson Dunn makes no representations as to the accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors or omissions therein, nor for any losses, injuries, or damages arising from its display or use.